BioSpace News Archive

This is the eighth patent issued, in the United States and other countries, for the Company’s brown fat technology related to BioRestorative’s metabolic program

Eceptionist has released a new software version with enhanced eConsult features for increasing access to specialty care and wait time reduction; this as more federal and state fee schedules include reimbursements for provider-to-provider encounters [12-December-2019] LONDON and HOUSTON , Dec. 12, 2019 /PRNewswire/ -- Eceptionist, a world leader in providing healthcare

Omada Health today announced that its digital care programs for Diabetes Prevention, Type 2 Diabetes, and Hypertension will be included on the Express Scripts Digital Health Formulary beginning in early 2020.

Arcadia customers received 2.5x the average bonus of other MSSP ACOs in 2018

DataPath, Inc., a leading developer of technology solutions for employer-sponsored benefits administration, announced today the release of a whitepaper titled, “Addressing Education Gaps is Key to TPA Growth.”

SilverCloud Health, one of the leading digital mental health platforms, today announced that Express Scripts, the largest independent manager of pharmacy benefits in the United States, will include SilverCloud’s evidenced-based digital mental health platform on its new digital health formulary in 2020.

Prostate Cancer Canada and the Canadian Cancer Society (CCS) are excited to announce their intention to embark upon a strategic amalgamation that will strengthen and support cancer research, education and the needs of Canadians and their families dealing with the disease.

Cure Alzheimer’s Fund, a non-profit dedicated to funding research with the highest probability of preventing, slowing, or reversing Alzheimer’s disease, today announced that it has reached an important milestone -- awarding more than $100 million in research funding.

Physicians’ Education Resource® (PER®), the nation’s leading resource for oncology and hematology continuing medical education (CME), will host the 17th Annual Winter Lung Cancer Conference™, Feb. 7-9, 2020, at Eden Roc Miami Beach in Miami Beach, Florida.

Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced that its collaborators at The Institute of Cancer Research, London, presented results from the cohort of patients in the plasmaMATCH trial treated with Puma’s drug neratinib at the 2019 San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas.